Daiichi Sankyo (Thailand) Ltd. clinical trials
A country office of Daiichi Sankyo
The registry lists 1 studies whose lead sponsor is Daiichi Sankyo (Thailand) Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 6, 2022.
Registry sponsor names on this page
- Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company1 study
Something wrong with this grouping? Tell us on the Daiichi Sankyo page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Daiichi Sankyo studies →
- Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)CompletedNCT03247569
Sponsor listed in the registry: Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company